Next Generation News and Research

RSS

New technology provides point of care insights to Rush oncologists

Rush University Medical Center is the first health care organization to launch medical record company Epic's module for genomic results, giving providers the tools they need to tailor patient care at the molecular level.

4 Feb 2020

Indivumed and Biognosys partnership aims to enhance proteomics insights

Indivumed, a physician-led, integrated global oncology solution provider, announced its partnership with Biognosys.

From Biognosys 4 Feb 2020

Sperm microbiome revealed with RNA sequencing

A new study reports the first-ever detailed description of the human sperm microbiome, using newer RNA sequencing techniques that are capable of discriminating between sperm RNA and that of bacterial contamination or colonization.

2 Feb 2020

New study lays foundation for next generation aortic grafts

A new study by researchers at McGill University has measured the dynamic physical properties of the human aorta, laying the foundation for the development of grafts capable of mimicking the native behaviour of the human body's largest artery.

30 Jan 2020

Highly active adults engage in a greater variety of activities to meet exercise guidelines

Highly active adults engage in a greater variety of physical activities than do less active adults, finds a new study led by researchers at NYU Rory Meyers College of Nursing.

29 Jan 2020

Porvair Sciences offers next generation microplate for phospholipid removal

Porvair Sciences announce Microluteä PLR - a new benchmark product for phospholipid removal. The 96-well microplate provides effective removal (>99%) of phospholipids and proteins with higher levels of reproducibility from plasma and serum samples while maintaining maximum recovery of target analytes.

From Chromatrap® - Porvair Sciences Ltd 29 Jan 2020

Study could lead to next-generation clinical testing for hidden hearing loss

A pair of biomarkers of brain function -- one that represents "listening effort," and another that measures ability to process rapid changes in frequencies -- may help to explain why a person with normal hearing may struggle to follow conversations in noisy environments, according to a new study led by Massachusetts Eye and Ear researchers.

28 Jan 2020

Parkinson's Foundation announces first-ever Physical Therapy Faculty Award

The Parkinson's Foundation announced that it has awarded its first-ever Parkinson's Foundation Physical Therapy Faculty Award to three physical therapists, totaling $30,000.

28 Jan 2020

NYU study provides better understanding of youth vaping patterns

While youth vaping rates have increased in recent years, most middle and high school students don't vape or smoke and very few vape or smoke daily, finds a study led by researchers at NYU School of Global Public Health.

27 Jan 2020

Meridian launches High-Specificity Pfu HS Mix to increase customers’ testing capabilities

Meridian Bioscience, Inc. today announced the launch of a High-Specificity Pfu HS Mix that not only provides high-fidelity amplification, but also offers market-leading amplification for companion diagnostic (CDx) and clinical testing.

From Meridian Bioscience, Inc. 24 Jan 2020

RB1 alterations in cancer cells may lead to treatment resistance

The Cancer Genetics Group of the Josep Carreras Leukaemia Research Institute, led by Montse Sánchez-Céspedes, together with Luis Montuenga from CIMA, and Enriqueta Felip from Vall d'Hebron Hospital, has revealed that inactivation of RB1 through intragenic rearrangements is frequent in lung cancer cells from non-smoking patients with EGFR mutations.

24 Jan 2020

Transcriptional scanning in the sperm may regulate rate of human evolution

Maturing sperm cells turn on most of their genes, not to follow their genetic instructions like normal, but instead to repair DNA before passing it to the next generation, a new study finds.

23 Jan 2020

The Science Behind the Beer and Brewing Industry

Beer consists primarily of four ingredients; water, malted grain, hops, and yeast. Yet, the analysis of beer and the brewing process has changed dramatically over the last decade. In this interview, Christopher Welch from the Indiana Consortium for Analytical Science and Engineering (ICASE) talks to News-Medical Life Sciences about the new and improving developments in the analytical chemistry of beer and brewing analysis.

From Pittcon 23 Jan 2020

Carterra closes financing round for continued growth of the LSA platform for next generation antibody discovery

Carterra Inc., the world leader in high-throughput antibody screening and characterization, has closed a $6M round of financing led by Ballast Point Ventures with participation from current investor, Telegraph Hill Partners.

From Carterra Inc. 23 Jan 2020

Synthego adopts good manufacturing practices for highest-quality genome engineering for clinical applications

Synthego, the genome engineering company, today announced it has adopted Good Manufacturing Practice standards to provide academic and industry partners with high-quality reagents for use in clinical research and development.

From Synthego Corporation 23 Jan 2020

BHF announces shortlist of four CVD research projects competing for £30 million award

The British Heart Foundation (BHF) today announced its shortlist of four research projects competing for a single £30 million award.

23 Jan 2020

MIT spin-out partners with Cambridge Consultants to co-develop the first Flowfect system

MIT spin-out company Kytopen has engaged Cambridge Consultants to co-develop the first Flowfect system.

22 Jan 2020

SITESEEKER to be used for Otsuka’s therapeutics discovery programs

PhoreMost will deploy its in-house expertise and next-generation phenotypic screening platform, SITESEEKER, in disease-relevant pathways nominated by Otsuka.

From PhoreMost 21 Jan 2020

First randomized clinical trial compares targeted therapies for acute lymphoblastic leukemia

Researchers from St. Jude Children's Research Hospital and the Chinese Children's Cancer Group led the first randomized, Phase III clinical trial comparing targeted therapies for acute lymphoblastic leukemia (ALL) driven by the Philadelphia chromosome.

17 Jan 2020

MDI Biological Laboratory will use African turquoise killifish model to study aging

The study of therapies and interventions to expand healthy human lifespan has been limited by a lack of animal models: traditional vertebrate models such as the mouse live too long to get rapid results, while the most popular model, a roundworm called C.elegans that lives for only three weeks, is rungs away from humans on the evolutionary ladder.

16 Jan 2020